Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1992-3-16
pubmed:abstractText
In this study, we have analyzed the effect of human alpha interferon (IFN-alpha) on a single replication cycle of human immunodeficiency virus type 1 (HIV-1) infection in the lymphocytic cell line CEM-174, which is highly sensitive to the antiviral effects of IFN. Pretreatment of cells with 50 to 500 U of recombinant human IFN-alpha per ml resulted in a marked reduction in viral RNA and protein synthesis. The effect of IFN-alpha was dose dependent and was amplified in multiple infection cycles. IFN-induced inhibition of viral protein synthesis could be detected only when cells were treated with IFN-alpha prior to infection or when IFN-alpha was added up to 10 h postinfection, but not if IFN-alpha was added at the later stages of HIV-1 replication cycle or after the HIV-1 infection was already established. Analysis of the integrated HIV-1 provirus showed a marked decrease in the levels of proviral DNA in IFN-treated cells. Thus, in contrast to the previous studies on established HIV-1 infection in T cells, in which the IFN block appeared to be at the posttranslational level, during de novo infection, IFN-alpha interferes with an early step of HIV-1 replication cycle that occurs prior to the integration of the proviral DNA. These results indicate that the early IFN block of HIV-1 replication, which has been previously observed only in primary marcophages, can also be detected in the IFN-sensitive T cells, indicating that the early IFN block is not limited to macrophages.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-1688522, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-1692347, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-1707604, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-1976701, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2014240, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2331748, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2425014, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2434505, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2440675, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2466937, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2470148, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2472636, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2474832, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2496708, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2760980, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2849111, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2922280, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-2925627, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-3016298, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-3100665, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-3113463, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-3144996, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-3257102, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-3261888, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-3878228, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-4071980, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-518835, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-57667, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-6165284, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-6177094, http://linkedlifedata.com/resource/pubmed/commentcorrection/1738192-6180173
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1321-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.
pubmed:affiliation
Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't